Upregulation of the vascular endothelial growth factor (VEGF), a key mediator of these vascular changes, has been implicated in the development of dyskinesia in the PD, and inhibition of the VEGF signaling attenuated the development of LID49. Here, VEGFA is linked to drug-induced dyskinesia.